Epigenetic dysregulation of ID4 predicts disease progression and treatment outcome in myeloid malignancies

DLX4 hypermethylation is a prognostically adverse indicator in de novo acute myeloid leukemia

(2016) Jing-dong Zhou et al.   TUMOR BIOLOGY

The prognostic implication of SRSF2 mutations in Chinese patients with acute myeloid leukemia

(2016) Jing Yang et al.   TUMOR BIOLOGY

Molecular mechanisms of the progression of myelodysplastic syndrome to secondary acute myeloid leukaemia and implication for therapy

(2015) Chunli Dan et al.   ANNALS OF MEDICINE

Chronic myeloid leukaemia

(2015) Jane F Apperley   LANCET

CEBPA methylation and mutation in myelodysplastic syndrome

(2015) Xiang-mei Wen et al.   MEDICAL ONCOLOGY

Integrating genetics and epigenetics in myelodysplastic syndromes: advances in pathogenesis and disease evolution

(2014) Guillermo Montalbán Bravo et al.   BRITISH JOURNAL OF HAEMATOLOGY

MiR-378 Promotes the Migration of Liver Cancer Cells by Down-Regulating Fus Expression

(2014) Jichun Ma et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

DNA methylation dynamics during epigenetic reprogramming in the germline and preimplantation embryos

(2014) D. M. Messerschmidt et al.   GENES & DEVELOPMENT

U2AF1mutations alter splice site recognition in hematological malignancies

(2014) Janine O. Ilagan et al.   GENOME RESEARCH

The role of mutations in epigenetic regulators in myeloid malignancies

(2014) Brittany A. Woods et al.   IMMUNOLOGICAL REVIEWS

Myelodysplastic syndromes

(2014) Lionel Adès et al.   LANCET

Overexpression of BAALC: clinical significance in Chinese de novo acute myeloid leukemia

(2014) Jing-dong Zhou et al.   MEDICAL ONCOLOGY

Detection of SRSF2-P95 Mutation by High-Resolution Melting Curve Analysis and Its Effect on Prognosis in Myelodysplastic Syndrome

(2014) Jiang Lin et al.   PLoS One

Quantitative methodology is critical for assessing DNA methylation and impacts on correlation with patient outcome

(2014) Annette M Lim et al.   Clinical Epigenetics

Clinical and biological implications of driver mutations in myelodysplastic syndromes

(2013) E. Papaemmanuil et al.   BLOOD

RAS mutation analysis in a large cohort of Chinese patients with acute myeloid leukemia

(2013) Xiaofei Yang et al.   CLINICAL BIOCHEMISTRY

Overexpressed let-7a-3 is associated with poor outcome in acute myeloid leukemia

(2013) Yun Li et al.   LEUKEMIA RESEARCH

Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia

(2013)   NEW ENGLAND JOURNAL OF MEDICINE

Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal

(2013) J. Gao et al.   Science Signaling

U2AF1 Mutations in Chinese Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome

(2012) Jun Qian et al.   PLoS One

The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.

(2012) Ethan Cerami et al.   Cancer Discovery

IDH1 and IDH2 mutation analysis in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome

(2011) Jiang Lin et al.   ANNALS OF HEMATOLOGY

Molecular Genetics of Adult Acute Myeloid Leukemia: Prognostic and Therapeutic Implications

(2011) Guido Marcucci et al.   JOURNAL OF CLINICAL ONCOLOGY

Recurrent DNMT3A R882 Mutations in Chinese Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome

(2011) Jiang Lin et al.   PLoS One

Epstein-Barr virus-specific methylation of human genes in gastric cancer cells

(2011) Julie L Ryan et al.   Infectious Agents and Cancer

Silencing of the inhibitor of DNA binding protein 4 (ID4) contributes to the pathogenesis of mouse and human CLL

(2010) S.-S. Chen et al.   BLOOD

Cancer Epigenetics

(2010) Rodolphe Taby et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer

(2009) Jason PW Carey et al.   BMC CANCER

ID4 methylation predicts high risk of leukemic transformation in patients with myelodysplastic syndrome

(2009) Hong Wang et al.   LEUKEMIA RESEARCH

Chromosomal translocations: revisited yet again

(2008) J. D. Rowley   BLOOD

Aberrant DNA methylation is a dominant mechanism in MDS progression to AML

(2008) Y. Jiang et al.   BLOOD

Promoter methylation-associated loss of ID4expression is a marker of tumour recurrence in human breast cancer

(2008) Erik Noetzel et al.   BMC CANCER